AMICUS THERAPEUTICS, INC. — Director's Dealing 2018

Mar 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2018-03-09

Reporting Person: Quimi Daphne (SVP, Finance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-09	Common stock	M	8750	$5.96	Acquired	73082	Direct
2018-03-09	Common stock	S	8750	$15.00	Disposed	64332	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-09	Stock Options (right to buy)	$5.96	M	8750	Disposed	2021-01-19	Common stock (8750)	Direct

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.

F2: All of the options were fully vested and exercisable as of March 9, 2018.